全球数位疗法市场规模、份额、趋势和成长分析报告（2026-2034）

数位疗法市场预计将从 2025 年的 106 亿美元成长到 2034 年的 996.7 亿美元，2026 年至 2034 年的复合年增长率为 28.28%。

随着医疗服务提供者采用技术主导的治疗方案，全球数位疗法市场正在快速成长。数位疗法利用软体为基础的程序，透过实证干预措施来治疗、管理或预防疾病。这些解决方案通常透过行动应用程式、穿戴式装置和线上平台提供。

多种因素正在推动数位疗法市场的成长。慢性病盛行率的上升和数位医疗技术的广泛应用，促进了基于软体的治疗工具的开发。医疗服务提供者也在探索数位疗法，将其作为一种经济有效的解决方案，以提高患者的参与度和治疗依从性。

随着医疗保健系统拥抱数位转型，数位疗法市场预计将会扩张。人工智慧、数据分析和远端监测技术的进步有望改善治疗效果。随着患者和医疗服务提供者越来越多地采用数位健康工具，数位疗法将成为现代医学的关键组成部分。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章：全球数位治疗药物市场：按应用领域划分

• 市场分析、洞察与预测
• 糖尿病
• 肥胖
• CVD
• 呼吸系统疾病
• 禁止抽烟
• 中枢神经系统疾病
• 其他的

第五章：全球数位治疗药物市场：依最终用途划分

• 市场分析、洞察与预测
• 病人
• 提供者
• 付款人
• 雇主
• 其他的

第六章 全球数位治疗药物市场：按地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第七章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第八章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Omada Health Inc
  • Welldoc Inc
  • 2Morrow Inc
  • Livongo Health Inc.（Teladoc Health Inc.）
  • Propeller Health（ResMed）
  • Fitbit LLC
  • Mango Health
  • Canary Health
  • Noom Inc
  • Pear Therapeutics Inc
  • Akili Interactive Labs Inc
  • Hygieia
  • DarioHealth Corp
  • BigHealth
  • GAIA AG
  • Limbix Health Inc

The Digital Therapeutics Market size is expected to reach USD 99.67 Billion in 2034 from USD 10.60 Billion (2025) growing at a CAGR of 28.28% during 2026-2034.

The global digital therapeutics market has grown rapidly as healthcare providers adopt technology-driven treatment solutions. Digital therapeutics use software-based programs to treat, manage, or prevent medical conditions through evidence-based interventions. These solutions are commonly delivered through mobile applications, wearable devices, and online platforms.

Several drivers are supporting the growth of the digital therapeutics market. Increasing prevalence of chronic diseases and growing adoption of digital health technologies have encouraged the development of software-based treatment tools. Healthcare providers are also exploring digital therapeutics as cost-effective solutions that improve patient engagement and treatment adherence.

Looking ahead, the digital therapeutics market is expected to expand as healthcare systems embrace digital transformation. Advances in artificial intelligence, data analytics, and remote monitoring technologies may enhance treatment effectiveness. As patients and providers increasingly adopt digital health tools, digital therapeutics will likely become an important component of modern healthcare.

MARKET SEGMENTATION

By Application

• Diabetes
• Obesity
• CVD
• Respiratory Diseases
• Smoking Cessation
• CNS Diseases
• Others

By End Use

• Patients
• Providers
• Payers
• Employers
• Others

COMPANIES PROFILED

• Omada Health Inc, Welldoc Inc, 2Morrow Inc, Livongo Health Inc Teladoc Health Inc, Propeller Health ResMed, Fitbit LLC, Mango Health, Canary Health, Noom Inc, Pear Therapeutics Inc, Akili Interactive Labs Inc, Hygieia, DarioHealth Corp, BigHealth, GAIA AG, Limbix Health Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL DIGITAL THERAPEUTICS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Application
• 4.2. Diabetes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Obesity Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. CVD Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Respiratory Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Smoking Cessation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. CNS Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.8. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL DIGITAL THERAPEUTICS MARKET: BY END USE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast End Use
• 5.2. Patients Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Providers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Payers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Employers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL DIGITAL THERAPEUTICS MARKET: BY REGION 2022-2034 (USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Application
  • 6.2.2 By End Use
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Application
  • 6.3.2 By End Use
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Application
  • 6.4.2 By End Use
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Application
  • 6.5.2 By End Use
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Application
  • 6.6.2 By End Use
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL DIGITAL THERAPEUTICS INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Omada Health Inc
  • 8.2.2 Welldoc Inc
  • 8.2.3 2Morrow Inc
  • 8.2.4 Livongo Health Inc. (Teladoc Health Inc.)
  • 8.2.5 Propeller Health (ResMed)
  • 8.2.6 Fitbit LLC
  • 8.2.7 Mango Health
  • 8.2.8 Canary Health
  • 8.2.9 Noom Inc
  • 8.2.10 Pear Therapeutics Inc
  • 8.2.11 Akili Interactive Labs Inc
  • 8.2.12 Hygieia
  • 8.2.13 DarioHealth Corp
  • 8.2.14 BigHealth
  • 8.2.15 GAIA AG
  • 8.2.16 Limbix Health Inc